DK1163008T3 - Anvendelse af trehalose til stabilisering af en flydende vaccine - Google Patents
Anvendelse af trehalose til stabilisering af en flydende vaccineInfo
- Publication number
- DK1163008T3 DK1163008T3 DK00912734T DK00912734T DK1163008T3 DK 1163008 T3 DK1163008 T3 DK 1163008T3 DK 00912734 T DK00912734 T DK 00912734T DK 00912734 T DK00912734 T DK 00912734T DK 1163008 T3 DK1163008 T3 DK 1163008T3
- Authority
- DK
- Denmark
- Prior art keywords
- trehalose
- liquid vaccine
- stabilize
- vaccine composition
- liquid
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 title abstract 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 title abstract 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 title abstract 3
- 239000007788 liquid Substances 0.000 title abstract 3
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 230000003019 stabilising effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9903765A FR2791895B1 (fr) | 1999-03-23 | 1999-03-23 | Utilisation de trehalose pour stabiliser un vaccin liquide |
| PCT/FR2000/000730 WO2000056365A1 (fr) | 1999-03-23 | 2000-03-23 | Utilisation de trehalose pour stabiliser un vaccin liquide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1163008T3 true DK1163008T3 (da) | 2003-11-17 |
Family
ID=9543654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00912734T DK1163008T3 (da) | 1999-03-23 | 2000-03-23 | Anvendelse af trehalose til stabilisering af en flydende vaccine |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1163008B1 (da) |
| JP (1) | JP2002540079A (da) |
| AT (1) | ATE246937T1 (da) |
| AU (1) | AU3438900A (da) |
| CA (1) | CA2366869A1 (da) |
| DE (1) | DE60004496T2 (da) |
| DK (1) | DK1163008T3 (da) |
| ES (1) | ES2200845T3 (da) |
| FR (1) | FR2791895B1 (da) |
| PT (1) | PT1163008E (da) |
| WO (1) | WO2000056365A1 (da) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997025429A1 (en) | 1996-01-04 | 1997-07-17 | Rican Limited | Helicobacter pylori bacterioferritin |
| GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
| EP2351579B1 (en) | 2002-10-11 | 2016-09-21 | Novartis Vaccines and Diagnostics S.r.l. | Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages |
| CN101926988B (zh) | 2003-01-30 | 2014-06-04 | 诺华疫苗和诊断有限公司 | 抗多种脑膜炎球菌血清组的可注射性疫苗 |
| GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
| PT1961426E (pt) | 2003-10-02 | 2011-06-28 | Novartis Vaccines & Diagnostic | Vacinas combinadas contra a meningite |
| GB0406013D0 (en) | 2004-03-17 | 2004-04-21 | Chiron Srl | Analysis of saccharide vaccines without interference |
| MX2008014391A (es) * | 2006-05-12 | 2009-03-06 | Bharat Biotech Int Ltd | Una composicion util como vacuna. |
| EP2491947A3 (en) | 2006-09-07 | 2012-10-17 | GlaxoSmithKline Biologicals S.A. | Vaccine |
| EP2682127A1 (en) | 2007-05-02 | 2014-01-08 | GlaxoSmithKline Biologicals S.A. | Vaccine |
| BRPI0816790A8 (pt) | 2007-09-14 | 2017-05-16 | Sanofi Pasteur Biologics Co | Composições farmacêuticas contendo toxóides a e b de clostridium difficile |
| EP2106788A1 (en) * | 2008-04-04 | 2009-10-07 | Ipsen Pharma | Liquid and freeze dried formulations |
| CN102596254B (zh) | 2009-09-30 | 2016-10-19 | 诺华股份有限公司 | 金黄色葡萄球菌5型和8型荚膜多糖的偶联 |
| BR112012022669A2 (pt) | 2010-03-10 | 2017-02-14 | Glaxosmithkline Biologicals Sa | composição imunogênica, método de tratamento ou prevenção de infecção ou doença, uso de um antígeno, kit, métodos para a fabricação de uma composição imunogênica e para melhorar uma vacina. |
| GB201101665D0 (en) | 2011-01-31 | 2011-03-16 | Novartis Ag | Immunogenic compositions |
| GB201016969D0 (en) | 2010-10-08 | 2010-11-24 | Genome Res Ltd | Expression system |
| CN102793919A (zh) | 2011-05-20 | 2012-11-28 | 日东电工株式会社 | 医药组合物及医药组合物的制造方法 |
| EP2755683B1 (en) | 2011-09-14 | 2019-04-03 | GlaxoSmithKline Biologicals SA | Methods for making saccharide-protein glycoconjugates |
| WO2013083753A2 (en) | 2011-12-07 | 2013-06-13 | Institut Pasteur | Identification of a swine parecho-like virus and applications |
| EP2852414B9 (en) | 2012-05-22 | 2020-12-09 | GlaxoSmithKline Biologicals SA | Meningococcus serogroup x conjugate |
| FR2992656B1 (fr) * | 2012-07-02 | 2016-10-07 | Sanofi Pasteur | Procede de production d'antigenes haemophilus influenzae type b |
| CN104487086B (zh) * | 2012-07-07 | 2019-08-30 | 巴拉特生物技术国际有限公司 | 无动物源的不含酒精的疫苗组合物及其制备方法 |
| MX2015002482A (es) | 2012-10-03 | 2016-01-08 | Glaxosmithkline Biolog Sa | Composicion inmunogenica. |
| SI3421997T1 (sl) | 2012-12-28 | 2020-10-30 | Cellestis Limited | Test celično posredovanega imunskega odziva |
| WO2017175082A1 (en) | 2016-04-05 | 2017-10-12 | Gsk Vaccines S.R.L. | Immunogenic compositions |
| LT3506935T (lt) | 2016-09-02 | 2024-04-25 | Sanofi Pasteur, Inc. | Vakcina nuo neisseria meningitidis |
| WO2018048869A1 (en) | 2016-09-06 | 2018-03-15 | Bioventures, Llc | Compositions and methods for generating reversion free attenuated and/or replication incompetent vaccine vectors |
| EP3370065A1 (en) | 2017-03-03 | 2018-09-05 | Treos Bio Kft | Immunogenic peptides |
| EP3369431A1 (en) | 2017-03-03 | 2018-09-05 | Treos Bio Kft | Vaccine |
| MA47683A (fr) | 2017-03-03 | 2020-01-08 | Treos Bio Zrt | Plate-forme d'identification de peptide immunogène reposant sur une population |
| CA3110760A1 (en) | 2018-09-04 | 2020-03-12 | Treos Bio Limited | Peptide vaccines |
| GB201814362D0 (en) | 2018-09-04 | 2018-10-17 | Treos Bio Zrt | Composition and process for preparing vaccine |
| EP3876982A1 (en) | 2018-11-06 | 2021-09-15 | GlaxoSmithKline Biologicals S.A. | Immunogenic compositions |
| GB201908332D0 (en) | 2019-06-11 | 2019-07-24 | Univ Oxford Innovation Ltd | Assays and inhibitors of oxygen-dependent N-terminal oxidation |
| GB202004974D0 (en) | 2020-04-03 | 2020-05-20 | Treos Bio Ltd | Coronavirus vaccine |
| CA3174505A1 (en) | 2020-04-03 | 2021-10-07 | Zsolt CSISZOVSZKI | Coronavirus vaccine |
| WO2022268916A2 (en) | 2021-06-23 | 2022-12-29 | Ose Immunotherapeutics | Pan-coronavirus peptide vaccine |
| GB202109082D0 (en) | 2021-06-24 | 2021-08-11 | Univ Oxford Innovation Ltd | Polypeptides and uses thereof |
| CN118647394A (zh) | 2022-02-03 | 2024-09-13 | 赛科维有限两合公司 | 使用cd4和cd8抗原的共疫苗接种 |
| GB202208695D0 (en) | 2022-06-14 | 2022-07-27 | Univ Oxford Innovation Ltd | Antibacterials |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2748132A1 (de) * | 1977-10-27 | 1979-05-03 | Behringwerke Ag | Stabilisator fuer polysaccharid |
| US4902506A (en) * | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
| IL78775A (en) * | 1985-05-15 | 1992-06-21 | Biotech Australia Pty Ltd | Oral vaccines |
| DE69419966T2 (de) * | 1993-05-17 | 2000-01-20 | Akzo Nobel N.V., Arnheim/Arnhem | Impstoff gegen Streptococcus suis-Infektion |
| ES2194911T3 (es) * | 1994-06-02 | 2003-12-01 | Elan Drug Delivery Ltd | Metodo para evitar la agregacion de proteinas/peptidos cuando tiene lugar su rehidratacion o descongelacion. |
| AU739916B2 (en) * | 1996-09-26 | 2001-10-25 | Merck Sharp & Dohme Corp. | Rotavirus vaccine formulations |
| US6210683B1 (en) * | 1997-09-05 | 2001-04-03 | Merck & Co., Inc. | Stabilizers containing recombinant human serum albumin for live virus vaccines |
-
1999
- 1999-03-23 FR FR9903765A patent/FR2791895B1/fr not_active Expired - Fee Related
-
2000
- 2000-03-23 AU AU34389/00A patent/AU3438900A/en not_active Abandoned
- 2000-03-23 WO PCT/FR2000/000730 patent/WO2000056365A1/fr active IP Right Grant
- 2000-03-23 JP JP2000606269A patent/JP2002540079A/ja active Pending
- 2000-03-23 PT PT00912734T patent/PT1163008E/pt unknown
- 2000-03-23 CA CA002366869A patent/CA2366869A1/en not_active Abandoned
- 2000-03-23 DE DE60004496T patent/DE60004496T2/de not_active Expired - Fee Related
- 2000-03-23 DK DK00912734T patent/DK1163008T3/da active
- 2000-03-23 AT AT00912734T patent/ATE246937T1/de not_active IP Right Cessation
- 2000-03-23 EP EP00912734A patent/EP1163008B1/fr not_active Expired - Lifetime
- 2000-03-23 ES ES00912734T patent/ES2200845T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2200845T3 (es) | 2004-03-16 |
| FR2791895B1 (fr) | 2001-06-15 |
| CA2366869A1 (en) | 2000-09-28 |
| DE60004496D1 (de) | 2003-09-18 |
| ATE246937T1 (de) | 2003-08-15 |
| DE60004496T2 (de) | 2004-04-08 |
| PT1163008E (pt) | 2003-12-31 |
| WO2000056365A1 (fr) | 2000-09-28 |
| AU3438900A (en) | 2000-10-09 |
| EP1163008B1 (fr) | 2003-08-13 |
| FR2791895A1 (fr) | 2000-10-13 |
| EP1163008A1 (fr) | 2001-12-19 |
| JP2002540079A (ja) | 2002-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1163008T3 (da) | Anvendelse af trehalose til stabilisering af en flydende vaccine | |
| CY2019029I2 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις | |
| UA93855C2 (ru) | Вакцина, способствует росту, базирующейся ha нейтрализующем эпитопе | |
| CY1112687T1 (el) | Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες | |
| ID26033A (id) | Metode penstabilan komposisi bahan farmasi dengan penggunaan khusus dari antioksidan | |
| ATE289640T1 (de) | Amidofunktionelle aminopolydiorganosiloxane | |
| DE60144145D1 (de) | Subtilisin-variante | |
| DK1914244T3 (da) | Fremgangsmåde til at modulere aktiviteten af funktionelle immunmolekyler. | |
| ATE223702T1 (de) | Verfahren und zusammensetzungen zur mikrokapselung von adjuvantien | |
| DE60007095T2 (de) | Calanolide zur hemmung von btk | |
| DE60125797D1 (de) | Impfstoffzusammesetzung | |
| FI20012281A0 (fi) | Menetelmä ja järjestelmä personoitujen sanomien synnyttämiseksi | |
| MY150893A (en) | Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines | |
| DK1123414T3 (da) | Antisense-modulering af integrin alpha 4.ekspression | |
| ATE551069T1 (de) | Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung | |
| NO20031860L (no) | Kahalalid F | |
| DK1235579T3 (da) | Farmaceutiske præparater med indhold af trimegeston | |
| ATE352315T1 (de) | Neospora impstoff | |
| ATE424217T1 (de) | Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen | |
| DE60222296D1 (de) | Impfstoff von umhüllten viren und verfahren zu seiner herstellung | |
| BR0110205A (pt) | Inibidores de peptìdeo deformilase | |
| DK1159426T3 (da) | Kloning og udtryk af Haemophilus somnus transferrin-bindende proteiner | |
| ATE255594T1 (de) | Hepatitis b inhibitoren | |
| IT1308583B1 (it) | Procedimento di consolidamento per terreni ed edifici. | |
| ATE375170T1 (de) | Adjuvanskombinationen zur immunisierung und vakzine |